Literature DB >> 21729004

Pathway analysis of NAD+ metabolism.

Luis F de Figueiredo1, Toni I Gossmann, Mathias Ziegler, Stefan Schuster.   

Abstract

NAD(+) is well known as a crucial cofactor in the redox balance of metabolism. Moreover, NAD(+) is degraded in ADP-ribosyl transfer reactions, which are important components of multitudinous signalling reactions. These include reactions linked to DNA repair and aging. In the present study, using the concept of EFMs (elementary flux modes), we established all of the potential routes in a network describing NAD(+) biosynthesis and degradation. All known biosynthetic pathways, which include de novo synthesis starting from tryptophan as well as the classical Preiss-Handler pathway and NAD(+) synthesis from other vitamin precursors, were detected as EFMs. Moreover, several EFMs were found that degrade NAD(+), represent futile cycles or have other functionalities. The systematic analysis and comparison of the networks specific for yeast and humans document significant differences between species with regard to the use of precursors, biosynthetic routes and NAD(+)-dependent signalling. © The Authors Journal compilation
© 2011 Biochemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21729004     DOI: 10.1042/BJ20110320

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

Review 1.  Metabolic regulation of histone post-translational modifications.

Authors:  Jing Fan; Kimberly A Krautkramer; Jessica L Feldman; John M Denu
Journal:  ACS Chem Biol       Date:  2015-01-16       Impact factor: 5.100

Review 2.  Systems Biology Approaches to Redox Metabolism in Stress and Disease States.

Authors:  Rui-Sheng Wang; William M Oldham; Bradley A Maron; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2017-12-20       Impact factor: 8.401

3.  Identification of evolutionary and kinetic drivers of NAD-dependent signaling.

Authors:  Mathias Bockwoldt; Dorothée Houry; Marc Niere; Toni I Gossmann; Ines Reinartz; Alexander Schug; Mathias Ziegler; Ines Heiland
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-24       Impact factor: 11.205

Review 4.  The NAD metabolome--a key determinant of cancer cell biology.

Authors:  Alberto Chiarugi; Christian Dölle; Roberta Felici; Mathias Ziegler
Journal:  Nat Rev Cancer       Date:  2012-09-28       Impact factor: 60.716

5.  Uridine monophosphate synthetase enables eukaryotic de novo NAD+ biosynthesis from quinolinic acid.

Authors:  Melanie R McReynolds; Wenqing Wang; Lauren M Holleran; Wendy Hanna-Rose
Journal:  J Biol Chem       Date:  2017-05-30       Impact factor: 5.157

6.  Exogenous supplemental NAD+ protect myocardium against myocardial ischemic/reperfusion injury in swine model.

Authors:  Xinrong Zhai; Wenzheng Han; Ming Wang; Shaofeng Guan; Xinkai Qu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

7.  Increasing NAD synthesis in muscle via nicotinamide phosphoribosyltransferase is not sufficient to promote oxidative metabolism.

Authors:  David W Frederick; James G Davis; Antonio Dávila; Beamon Agarwal; Shaday Michan; Michelle A Puchowicz; Eiko Nakamaru-Ogiso; Joseph A Baur
Journal:  J Biol Chem       Date:  2014-11-19       Impact factor: 5.157

Review 8.  NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism.

Authors:  Wusheng Xiao; Rui-Sheng Wang; Diane E Handy; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2017-07-28       Impact factor: 8.401

9.  Urothelial purine release during filling of murine and primate bladders.

Authors:  Leonie Durnin; Sebastien Hayoz; Robert D Corrigan; Andrew Yanez; Sang Don Koh; Violeta N Mutafova-Yambolieva
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-27

10.  Intracellular NAD(H) levels control motility and invasion of glioma cells.

Authors:  Remco van Horssen; Marieke Willemse; Anna Haeger; Francesca Attanasio; Tuba Güneri; Albrecht Schwab; Christian M Stock; Roberto Buccione; Jack A M Fransen; Bé Wieringa
Journal:  Cell Mol Life Sci       Date:  2013-01-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.